Tango Therapeutics, Inc. (TNGX)
8.67
+0.04
(+0.46%)
USD |
NASDAQ |
Dec 31, 10:35
Tango Therapeutics Profit Margin (Quarterly): 29.52% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Moderna, Inc. | -19.68% |
| Amicus Therapeutics, Inc. | 10.24% |
| EyePoint Plc | -6.18K% |
| XOMA Royalty Corp. | -- |
| Viking Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -56.44% |
| Return on Assets | -35.80% |
| Return on Invested Capital | -46.91% |
| Gross Profit Margin (Quarterly) | 98.97% |
| Operating Margin (Quarterly) | 26.15% |
| Return on Net Operating Assets | -215.6% |